🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. TAK-648

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. TAK-648 Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. TAK-659

    Takeda

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

  4. TAK-671

    Takeda

    Coronavirus Disease

    phase 1 small molecule terminated

    1 trial

  5. TAK-676

    Takeda

    Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule completed

    1 trial

  6. TAK-755

    Takeda

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

  7. TAK-781

    Takeda

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  8. TAK-788

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  9. TAK-792 30 mg

    Takeda

    Healthy Male Adults Participants

    phase 1 small molecule completed

    1 trial

  10. TAK-828

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  11. TAK-828

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  12. TAK-861, TAK-861, TAK-861

    Takeda

    Narcolepsy with Cataplexy (Narcolepsy Type 1)

    phase 1 small molecule active

    1 trial

  13. TAK-875 and Glimepiride

    Takeda

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  14. TAK-881

    Takeda

    Healthy Volunteers

    phase 1 mab completed

    3 trials

  15. TAK-906

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  16. TAK-906

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  17. TAK-906 Maleate

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  18. TAK-906 Oral Capsule

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. TAK-915

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-915 suspension

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. TAK-925

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  22. TAK-925

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. TAK-925

    Takeda

    Healthy Participants and Patients With Narcolepsy

    phase 1 small molecule completed

    1 trial

  24. TAK-925

    Takeda

    Idiopathic Hypersomnia

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources